An Act To Address the Opioid Crisis through Evidence-based Public Health Policy
Maine Legislature, Session 129, LD 1689
Committee: Health and Human Services
Sponsors: McCREIGHT, CLAXTON, MOORE, FECTEAU, GATTINE, HUBBELL, JORGENSEN
Amends: 17-A MRSA §1110, 17-A MRSA §1111, 17-A MRSA §1111-A, 17-A MRSA §1301, 22 MRSA §1341, 22 MRSA §2383-B, 32 MRSA §13787-A

Legislative Document
No. 1689
S.P. 554
In Senate, May 7, 2019
An Act To Address the Opioid Crisis through Evidence-based 
Public Health Policy
Reference to the Committee on Health and Human Services suggested and ordered printed.
DAREK M. GRANT
Secretary of the Senate
Presented by Senator SANBORN, L. of Cumberland.
Cosponsored by Representative McCREIGHT of Harpswell and
Senators: CLAXTON of Androscoggin, MOORE of Washington, Representatives: FECTEAU 
of Biddeford, GATTINE of Westbrook, HUBBELL of Bar Harbor, JORGENSEN of Portland.
Be it enacted by the People of the State of Maine as follows:
Sec. 1.  17-A MRSA §1110, sub-§1-A, as amended by PL 2001, c. 383, §132 and 
affected by §156, is repealed.
Sec. 2.  17-A MRSA §1110, sub-§1-B, ¶B, as enacted by PL 2001, c. 383, §133 
and affected by §156, is repealed.
Sec. 3.  17-A MRSA §1110, sub-§1-C, as amended by PL 2007, c. 695, Pt. A, 
§20, is repealed.
Sec. 4.  17-A MRSA §1111, as amended by PL 2007, c. 346, Pt. B, §4, is repealed.
Sec. 5.  17-A MRSA §1111-A, sub-§2, as enacted by PL 1981, c. 266, is 
amended to read:
2.   For purposes of this section, drug paraphernalia does not include hypodermic 
apparatus. Possession of, furnishing or trafficking in hypodermic apparatus constitute 
separate offenses under sections 1110 and 1111.
Sec. 6.  17-A MRSA §1301, sub-§6, as amended by PL 2011, c. 464, §22, is 
further amended to read:
6.   In addition to any other authorized sentencing alternative, the court shall impose a 
minimum fine of $400, none of which may be suspended, for a person convicted of a 
crime under section 1103; 1104; 1105-A; 1105-B; 1105-C; 1105-D; 1106; 1107-A; 1108; 
1109; 1110; 1111; 1111-A, subsection 4-A; 1116; 1117; or 1118.
Sec. 7.  22 MRSA §1341, sub-§1, as amended by PL 2015, c. 507, §1, is further 
amended to read:
1.  Certification of programs.  The Maine Center for Disease Control and 
Prevention may certify hypodermic apparatus exchange programs that meet the 
requirements established by rule under subsection 2, paragraphs A to D.
A.  The Maine Center for Disease Control and Prevention may not limit the number 
of hypodermic apparatuses provided by the programs to participants.
B.  The Maine Center for Disease Control and Prevention may not limit the number 
of hypodermic apparatuses that participants served by the programs may legally 
possess, transport or exchange.
Sec. 8.  22 MRSA §1341, sub-§2, ¶D, as amended by PL 2015, c. 507, §1, is 
repealed and the following enacted in its place:
D.  Distribution of educational material regarding:
(1)  The dangers associated with the use of used hypodermic apparatuses;
(2)  Safer drug use; and
(3)  Overdose prevention;
Sec. 9.  22 MRSA §1341, sub-§2, ¶¶E and F, as enacted by PL 2015, c. 507, §1, 
are amended to read:
E.  Application procedures for a certified hypodermic apparatus exchange program to 
apply for funds to operate the program, including, but not limited to, the purchase and 
disposal of hypodermic needles, naloxone hydrochloride and other safer drug use 
supplies;
F.  Criteria for the award of funds to certified hypodermic apparatus exchange 
programs; that, without limitation:
(1)  Provide for the distribution of naloxone hydrochloride;
(2)  Perform testing for HIV, AIDS and hepatitis C;
(3)  Are directed by a board that includes members with a history of drug use or 
that establish and maintain a client advisory board; and
(4)  Maintain referral agreements with or have the capacity to provide:
(a)  Psychosocial counseling services that are informed by the recognition of 
trauma;
(b)  Medication-assisted substance use treatment services; and
(c)  Infectious disease care;
Sec. 10.  22 MRSA §1341, sub-§4, as enacted by PL 2015, c. 507, §2, is amended 
to read:
4.  Funding.  This subsection governs the use of state funds for hypodermic 
apparatus exchange programs certified pursuant to this section.  This subsection is not 
intended to limit the ability of certified programs to secure other sources of funding or to 
discourage fund-raising for the purpose of operating such programs.  The Maine Center 
for Disease Control and Prevention shall allocate any funds appropriated for hypodermic 
apparatus exchange programs among new and existing certified programs based on rates 
of intravenous drug use and negative health outcomes related to drug use in the 
geographic area surrounding a program; if applicable, the amount of services historically 
provided by the certified program; the geographic distribution of services provided by the 
certified program; and other relevant factors.  The award of funds must occur not later 
than 60 days after the effective date of this subsection and annually thereafter based on 
the availability of funding.
Sec. 11.  22 MRSA §2383-B, sub-§6, as amended by PL 2015, c. 27, §1, is 
further amended to read:
6.  Lawful possession of hypodermic apparatuses by livestock owners; sale to 
livestock owners.  A person who owns livestock is authorized to possess and have 
control of hypodermic apparatuses for the purpose of administering antibiotics, vitamins 
and vaccines to treat medical conditions or promote the health of that person's livestock, 
and such possession and control are expressly authorized within the meaning of Title 
17-A, section 1111, subsection 1, paragraph A.  For the purposes of this subsection, 
"livestock" means cattle, equines, sheep, goats, swine, members of the genus Lama, 
poultry, rabbits and cervids as defined in Title 7, section 1333, subsection 1.
A.  An agricultural supply store authorized to sell hypodermic apparatuses pursuant 
to Title 32, section 13787-A, subsection 1 may furnish or sell, without limit in 
number, hypodermic apparatuses to a person authorized to possess and have control 
of hypodermic apparatuses pursuant to this subsection, and such furnishing or sale is 
expressly authorized within the meaning of Title 17-A, section 1110, subsection 1-B.
Sec. 12.  32 MRSA §13787-A, sub-§3, as amended by PL 2003, c. 688, Pt. A, 
§39, is repealed.
SUMMARY
This bill expands the scope and capabilities of hypodermic apparatus exchange 
programs certified by the Department of Health and Human Services, Maine Center for 
Disease Control and Prevention.  This bill requires the center to adopt rules that:
1. Allow the programs to distribute naloxone hydrochloride and other safer drug use 
supplies; and
2.  Expand the criteria a program must meet in order to be awarded funds, including 
distributing naloxone hydrochloride and other safer drug use supplies; providing HIV, 
AIDS and hepatitis C testing; and maintaining referral agreements or having the capacity 
to provide counseling services, medication-assisted treatment services and infectious 
disease care.
The center is also required to consider geographic distribution of services provided 
by a program when allocating funding.
This bill also amends the Maine Criminal Code to remove the crimes of furnishing 
hypodermic apparatuses and illegal possession of hypodermic apparatuses and makes 
changes to other statutes to reflect that decriminalization.